Major funding awarded to RI-MUHC scientists for innovative genomics geared to Quebec patients

Pioneering work to advance genomics and precision health treatments at the Research Institute of the McGill University Health Centre (RI-MUHC) has been rewarded by Génome Québec. Dr. Nada Jabado and Dr. Ruth Sapir-Hichhadze, the RI-MUHC scientists who received the reward, were among the winners of a nation-wide competition emphasizing precision treatments in genomics. Dr. Jabado’s work investigating brain cancer in children received $13 million in funding after emerging as one of the four winning projects in Quebec in Genome Canada’s 2017 Large-Scale Applied Research Project Competition Genomics and Precision Health. Also, Dr. Ruth Sapir-Pichhadze is a principal co-scientist on a $9.7 million project led by the University of British Columbia using genomic technologies to reduce the risk of antibody-mediated rejection (AMR).